What is the insulin correction factor (mg/dL per unit) for a patient whose total daily insulin lispro dose is 60 units?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Insulin Correction Factor Calculation

For a patient on 60 units total daily dose of insulin lispro, the insulin correction factor is 30 mg/dL per unit of insulin (calculated as 1800 ÷ 60 = 30).

Formula and Application

The 1800 rule is the standard formula for calculating the insulin sensitivity factor (ISF), also called the correction factor, for rapid-acting insulin analogs like lispro 1. This formula estimates how many mg/dL one unit of rapid-acting insulin will lower blood glucose:

  • ISF = 1800 ÷ Total Daily Dose (TDD)
  • For this patient: 1800 ÷ 60 = 30 mg/dL per unit

This means each unit of insulin lispro should lower blood glucose by approximately 30 mg/dL.

Important Clinical Considerations

This formula provides only a starting point and must be adjusted empirically based on individual patient response 1. Multiple factors can alter actual insulin sensitivity, making the calculated value an estimation rather than an absolute 1.

Key Adjustments Needed:

  • Diurnal variation exists: Morning correction doses typically require more insulin than afternoon or evening doses 2. The 1800 rule may be appropriate for morning corrections but overestimate sensitivity (underestimate insulin needs) later in the day 2.

  • Patient-specific factors affecting sensitivity include:

    • Age (elderly patients are more insulin-sensitive)
    • Renal function (impairment increases sensitivity)
    • Body weight and BMI
    • Concurrent medications (especially corticosteroids)
    • Acute illness or stress 1, 3

Insulin Action Time

Account for "insulin on board" from previous injections 1. Subcutaneous rapid-acting insulin has a duration of action of 4-6 hours 1. Giving correction doses too frequently without accounting for residual insulin activity leads to "stacking" and hypoglycemia.

Alternative Formulas

  • For regular insulin (not rapid-acting): Use 1500 ÷ TDD instead 1
  • Some research suggests 1500 ÷ TDD may be more accurate for rapid-acting analogs in certain populations 4, though the 1800 rule remains the guideline-recommended standard

Relationship to Other Insulin Parameters

The correction factor relates mathematically to other insulin dosing parameters 4:

  • Insulin-to-carbohydrate ratio (ICR) = 500 ÷ TDD (for rapid-acting insulin)
  • ICR × 5.14 ≈ ISF in pediatric populations 2
  • These relationships can help verify dosing calculations

Monitor glucose response closely after implementing any calculated correction factor and adjust based on actual glycemic outcomes rather than relying solely on formulas 1.

References

1
Guideline

american association of clinical endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan-2022 update.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2022

4
Research

How much do I give? Reevaluation of insulin dosing estimation formulas using continuous glucose monitoring.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2010

Related Questions

When the insulin‑to‑carbohydrate ratio is 1 unit per gram of carbohydrate and the correction factor is 1 unit per 50 mg/dL, what does a dose of 5 units per carbohydrate choice represent and what does the ratio 3/50 represent?
What should be the basal insulin glargine (Lantus) dose, insulin‑to‑carbohydrate ratio (ICR), and insulin sensitivity factor (ISF) for a 40‑year‑old man with type 1 diabetes, weight 73 kg, chronic kidney disease (creatinine 1.24 mg/dL, eGFR ≈ 75 mL/min) and a small acute kidney injury, who is on Lantus 14 U and fixed‑meal insulin lispro (Novolog) 18 U breakfast, 14 U lunch, 10 U dinner, received dexamethasone 48 hours ago, and required 2.5 U via IV insulin drip?
For a 46‑year‑old man with type 3c diabetes, weight 88 kg, creatinine 1.18 mg/dL (eGFR ≈ 77 mL/min) on Lantus (insulin glargine) 10 U daily, insulin‑to‑carbohydrate ratio 10 g per unit, insulin sensitivity factor 50 mg/dL per unit, with capillary glucose 263 mg/dL at 1700 h, 231 mg/dL at 0200 h, and 284 mg/dL at 0700 h after meals of 80 g, 82 g, and 34 g carbohydrates, what should the basal insulin dose, insulin sensitivity factor, and insulin‑to‑carbohydrate ratio be adjusted to?
What should the insulin-to-carbohydrate ratio for the 8 am NPH insulin dose be in a 62‑year‑old female with type 2 diabetes, weight 43.8 kg, on prednisone 20 mg daily, using 22 units NPH insulin and current ICR 15 for breakfast and lunch, given her recent blood glucose readings?
For a 61-year-old male weighing 104 kg with normal renal function, neutropenic fever, currently on Lantus (insulin glargine) 5 U daily with an insulin‑to‑carbohydrate ratio (ICR) of 1 U per 15 g carbohydrate and an insulin sensitivity factor (ISF) of 1 U per 25 mg/dL, and glucose readings of 215 mg/dL fasting, 152 mg/dL at 5 pm, and 233 mg/dL at 9 pm after a 98‑g carbohydrate dinner, what should the basal Lantus dose, ICR, and ISF be adjusted to?
How should acute membranous tonsillitis be managed in a 9-year-old child?
What is a comprehensive literature review of oritavancin, including its mechanism of action, spectrum of activity, pharmacokinetics, dosing, safety profile, resistance mechanisms, and clinical use compared with vancomycin?
What is the appropriate post‑exposure prophylaxis regimen for gonorrhea, chlamydia, and syphilis?
What does a neutrophil count greater than 20 cells/µL in cerebrospinal fluid indicate, and what is the recommended management?
What sinus pathologies can cause referred otalgia?
What does total daily dose (TDD) refer to in insulin therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.